Skip to main content

Fecal viral shedding in COVID-19 patients: Clinical significance, viral load dynamics and survival analysis.

Wang X, Zheng J, Guo L, Yao H, Wang L, Xia X, Zhang W

Publication: Virus Res (2020) • Vol 289 • Page 198147PMID: 32866537View on PubMed

Purpose

This paper compared the detection of SARS-CoV-2, the virus that causes the novel 2019 coronavirus disease (COVID, COVID-19, COVID19), and viral shedding durations in fecal and oropharyngeal specimens. Correlations between SARS-CoV-2 detection in feces and patient age, gender, clinical symptoms, chest CT results, and laboratory testing results [neutrophil counts, leukocyte counts, lymphocyte counts, C-reactive protein (CRP) levels, albumin levels, alanine transaminase (ALT) levels, fibrinogen levels, and D-dimer levels] were also investigated.

Conclusion

SARS-CoV-2 RNA was found in fecal specimens of 28.99% patients and the median age of these patients was significantly younger than the patients in which viral RNA was not detected in feces. While the median duration for SARS-CoV-2 RNA detection was significantly longer in fecal specimens than oropharyngeal specimens, the duration of SARS-CoV-2 detection in oropharyngeal specimens was equivalent between patients with and without detection in the fecal specimens. Patients without detectable SARS-CoV-2 RNA in fecal specimens were significantly more likely to have fevers than those with SARS-CoV-2 RNA detected in the fecal specimens, but patients with detectable SARS-CoV-2 RNA in feces had significantly lower CRP and fibrinogen levels than patients with negative fecal specimens. No correlations between detection of SARS-CoV-2 RNA in fecal specimens and patient gender, neutrophil counts, leukocyte counts, lymphocyte counts, albumin levels, ALT levels, D-dimer levels, chest CT results, or clinical symptoms (fever, dry cough, cough with sputum, muscle ache, sore throat, breathlessness, chest tightness, fatigue, headache, nausea and vomiting, or diarrhea) were found.

Studies (1)

Purpose

This study compared SARS-CoV-2 detection and viral shedding durations in fecal and oropharyngeal specimens. Correlations between SARS-CoV-2 detection in feces and patient age, gender, clinical symptoms, chest CT results, and laboratory testing results (neutrophil counts, leukocyte counts, lymphocyte counts, CRP levels, albumin levels, ALT levels, fibrinogen levels, and D-dimer levels) were also investigated. Specimens were collected from 69 hospitalized patients (median age=49 y; 40 males, 29 females) diagnosed with COVID-19 every day until two sequential negative results in either the fecal or oropharyngeal specimen were obtained (details for collection, processing, storage, and RNA extraction not provided). Laboratory and chest CT results were conducted on admission and at the time of the last negative SARS-CoV-2 oropharyngeal specimen and fecal specimen (details not provided). The open reading frame (ORF1ab) and nucleoprotein (N) gene regions of SARS-CoV-2 were detected by real-time qRT-PCR and specimens were determined positive if CT value of both was <37.

Summary of Findings

SARS-CoV-2 RNA was found in fecal specimens of 20/69 (28.99%) patients and the median age of these patients was significantly younger than the patients in which viral RNA was not detected in the fecal specimen (43 y versus 52 y, P=0.003). Of these 20 patients, viral RNA was detected in the fecal specimen after loss of detection in the matched oropharyngeal specimen for 11 (55%) patients and SARS-CoV-2 RNA was first detected in the fecal specimen after loss of detection in the oropharyngeal specimen for 2 (10%) patients. While the median duration for SARS-CoV-2 RNA detection was significantly longer in fecal specimens than oropharyngeal specimens (25 d versus 16 d, P<0.001), there was no significant difference in the duration of oropharyngeal specimens testing SARS-CoV-2 positive between patients with and without detection in the matched fecal specimens (P>0.05). Patients without detectable SARS-CoV-2 RNA in fecal specimens were significantly more likely to have fevers than those with detection in the fecal specimens (58% vs 22%, P=0.039). Patients with SARS-CoV-2 detected in the fecal specimens had significantly lower CRP and fibrinogen levels than patients with negative fecal specimens (2.935 versus 13.9 mg/L, P=0.001 and 4.02 versus 5.15, P<0.001; respectively) even after correcting for effects of age and gender (P=0.017 and P=0.001, respectively). No correlations between detection of SARS-CoV-2 RNA in fecal specimens and patient gender, neutrophil counts, leukocyte counts, lymphocyte counts, albumin levels, ALT levels, D-dimer levels, chest CT results, or clinical symptoms (fever, dry cough, cough with sputum, muscle ache, sore throat, breathlessness, chest tightness, fatigue, headache, nausea and vomiting, or diarrhea) were found.

  • Biospecimens

    FluidFeces
    CellOral Cavity
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Pneumonia/Respiratory Infection
  • Platforms

    RNAReal-time qRT-PCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Chest CT results
    Different Clinical chemistry results
    Different hematological parameters
    Varying clinical symptoms
    PreaquisitionPatient age
    31.25-51.0 years
    PreaquisitionPatient gender
    Female
    Male
    Biospecimen AcquisitionBiospecimen location
    Feces
    Oropharyngeal swab
    Real-time qRT-PCR SpecificTargeted nucleic acid
    N gene region of SARS-CoV-2
    ORF1ab gene region of SARS-CoV-2